---
figid: PMC4997943__CCD-2-100_F2
figlink: /pmc/articles/PMC4997943/figure/F2/
number: Fig. (2)
caption: CEACAM6 Signaling Pathway. Over-expression of CEACAM6 results in alteration
  and reorganization of the ECM and activation of the TME playing a key role in tumor
  invasion. CEACAM6 signaling increases SRC activity leading to increased IGF-I secretion
  with autocrine and paracrine stimulation of the IGF-1R activating the PI3K/AKT pathway.
  Increased IGF-I expression results in MMP-2 elaboration, subsequently altering the
  ECM promoting a malignant TME. Aggregation of CEACAM6 at the cell surface enhances
  anoikis resistance through activation of SRC in a caveolin-1-dependent manner allowing
  for phosphorylation of its substrate focal adhesion kinase (FAK). TGF-β elaborated
  in the TME binds to the type II receptor (TβRII), promoting hetero-tetramerization
  with the type I receptor (TβRI) increasing the phosphorylation of SMAD3 by activated
  TβRI. Phosphorylated SMAD3 forms a complex with Co-Smad (SD4), which translocates
  into the nucleus to bind gene promoters and activate expression of target genes,
  specifically CEACAM6. Also, TGF-β signals through the TGF-β receptors to activate
  alternate pathways such as AKT/PI3K.
pmcid: PMC4997943
papertitle: Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion
  Molecule 6 (CEACAM6) in Human Malignancies.
reftext: Benny Johnson, et al. Clin Cancer Drugs. 2015 Feb;2(2):100-111.
pmc_ranked_result_index: '124113'
pathway_score: 0.9601285
filename: CCD-2-100_F2.jpg
figtitle: CEACAM6 Signaling Pathway
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4997943__CCD-2-100_F2.html
  '@type': Dataset
  description: CEACAM6 Signaling Pathway. Over-expression of CEACAM6 results in alteration
    and reorganization of the ECM and activation of the TME playing a key role in
    tumor invasion. CEACAM6 signaling increases SRC activity leading to increased
    IGF-I secretion with autocrine and paracrine stimulation of the IGF-1R activating
    the PI3K/AKT pathway. Increased IGF-I expression results in MMP-2 elaboration,
    subsequently altering the ECM promoting a malignant TME. Aggregation of CEACAM6
    at the cell surface enhances anoikis resistance through activation of SRC in a
    caveolin-1-dependent manner allowing for phosphorylation of its substrate focal
    adhesion kinase (FAK). TGF-β elaborated in the TME binds to the type II receptor
    (TβRII), promoting hetero-tetramerization with the type I receptor (TβRI) increasing
    the phosphorylation of SMAD3 by activated TβRI. Phosphorylated SMAD3 forms a complex
    with Co-Smad (SD4), which translocates into the nucleus to bind gene promoters
    and activate expression of target genes, specifically CEACAM6. Also, TGF-β signals
    through the TGF-β receptors to activate alternate pathways such as AKT/PI3K.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP4
  - IGF1
  - CASP2
  - CASP3
  - CASP5
  - CASP7
  - TGFBR2
  - TGFB1
  - TGFB2
  - TGFB3
  - VTN
  - CASP6
  - CASP12
  - CASP14
  - IGF1R
  - CASP10
  - CASP8
  - CASP9
  - CASP1
  - TGFBR1
  - SRC
  - SMAD3
  - PTK2
  - CEACAM6
  - MMP2
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: IGF-I
  symbol: IGF-I
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: TBRII
  symbol: TBRII
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Vitronectin
  symbol: VTN
  source: hgnc_symbol
  hgnc_symbol: VTN
  entrez: '7448'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: TBRI
  symbol: TBR-i
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: SMAD3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: CEACAM6
  symbol: CEACAM6
  source: hgnc_symbol
  hgnc_symbol: CEACAM6
  entrez: '4680'
- word: MMP-2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
chemicals: []
diseases: []
---
